Article Text

PDF
Letter
Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
  1. Prabha Ranganathan
  1. Correspondence to Dr Prabha Ranganathan, Division of Rheumatology, Box 8045, Washington University School of Medicine, St. Louis 63110, MO, USA; prangana{at}dom.wustl.edu

Statistics from Altmetric.com

We read with interest the study conducted by Galloway and colleagues on the risk of skin and soft tissue infections (SSTI) and herpes zoster (HZ) in patients with rheumatoid arthritis (RA) treated with tumour necrosis factor (TNF) antagonists versus non-biologic disease-modifying antirheumatic drugs (nbDMARDs).1 This study highlights the occurrence of common infections, such as SSTI and more uncommon infections such as HZ, when TNF antagonists and nbDMARDs are used in patients with RA with several …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.